Please login to the form below

Not currently logged in
Email:
Password:

Poxel

This page shows the latest Poxel news and features for those working in and with pharma, biotech and healthcare.

Metavant/Poxel prep phase 3 for imeglimin in diabetic kidney disease

Metavant/Poxel prep phase 3 for imeglimin in diabetic kidney disease

Treatment can help patients with advanced disease, companies say. Emboldened by new clinical data, French biotech Poxel and partner Metavant are planning a phase 3 programme in the US and Europe ... Imeglimin is thought to work against mitochondrial

Latest news

  • After Axovant shock, Roivant pens diabetes deal with Poxel After Axovant shock, Roivant pens diabetes deal with Poxel

    Hard on the heels of the Axovant news, parent company Roivant announced that it had signed a development and licensing deal with French biotech Poxel for imeglimin, a candidate originally discovered ... Poxel says imeglimin is in a new class of oral

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics